Michael Dougherty joined Marinus Pharmaceuticals Inc.'s board as a director.
Dougherty was most recently Celator Pharmaceuticals Inc.'s executive chairman.
Discover more about S&P Global’s offerings
Marinus appoints director
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Michael Dougherty joined Marinus Pharmaceuticals Inc.'s board as a director.
Dougherty was most recently Celator Pharmaceuticals Inc.'s executive chairman.